Ethnopharmacology, pharmacokinetics, and antitumor potential of Resina Draconis (Dragon's Blood): A systematic review connecting traditional use to molecular mechanisms
Journal of Ethnopharmacology · 2026-08 · 367 · 121702
DOI: 10.1016/j.jep.2026.121702 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Ethnopharmacology, 2026-08. Verfasst von Wei Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing and Rehabilitation, Nantong University, Nantong, Jiangsu, PR China. Electronic address: runner1111@163.com. Hauptthemen laut MEDLINE: Plant Extracts, Antineoplastic Agents, Phytogenic, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE Resina Draconis is a prestigious traditional Chinese medicine agent used to invigorate blood and resolve stasis. In traditional theory, malignancies are often characterized by severe blood stasis and pathological accumulation ("Zhengjia"). Thus, its traditional stasis-resolving efficacy offers a rationale for cancer therapy. AIM OF THE STUDY This review aims to summarize its major constituents and anti-tumor potentials, providing a scientific basis for its ethnopharmacological application in treating malignancies. MATERIALS AND METHODS Comprehensive and systematic review of the literature was performed across Web of Science (WOS), PubMed, China National Knowledge Infrastructure (CNKI), Scopus, and EMBASE up to December 2025, employing "Resina Draconis", "anticancer" and their synonyms as key words. Studies on Resina Draconis's antitumor effects, phytochemistry, pharmacokinetics, and mechanisms were included, while non-neoplastic studies and combination formulations were excluded. Data were narratively synthesized. RESULTS Thirty-three studies were included. Resina Draconis's antitumor activity is primarily attributed to flavonoids (e.g., loureirin A/B, cochinchinenin A) and non-flavonoid constituents (e.g., steroidal saponins). These components induce apoptosis, inhibit proliferation/metastasis, and modulate key pathways (e.g., MAPK, mTOR, PI3K/AKT). Pharmacokinetic studies revealed rapid absorption and tissue distribution (highest in liver/kidneys), with altered profiles under simulated weightlessness. In vivo models confirmed significant tumor suppression in hepatocellular, gastric, and oral cancers, with synergistic multi-target mechanisms enhancing efficacy. CONCLUSION Resina Draconis exhibits compelling antitumor potential through diverse bioactive compounds and multi-mechanistic actions. However, clinical evidence remains limited, and pharmacokinetic variability under specific conditions warrants attention. Future research should prioritize structure-activity relationship studies, standardized extraction protocols, advanced delivery systems, and rigorous clinical trials to translate Resina Draconis into viable anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nursing and Rehabilitation, Nantong University, Nantong, Jiangsu, PR China. Electronic address: runner1111@163.com.
- School of Nursing and Rehabilitation, Nantong University, Nantong, Jiangsu, PR China. Electronic address: 2476288493@qq.com.
- School of Nursing and Rehabilitation, Nantong University, Nantong, Jiangsu, PR China. Electronic address: 1328442622@qq.com.
- School of Nursing and Rehabilitation, Nantong University, Nantong, Jiangsu, PR China; Gulfreen Nursing College Avicenna Hospital Bedian, Lahore, Pakistan. Electronic address: attiqbsn17@gmail.com.
- School of Nursing and Rehabilitation, Nantong University, Nantong, Jiangsu, PR China. Electronic address: dreamnt@126.com.
- School of Nursing and Rehabilitation, Nantong University, Nantong, Jiangsu, PR China. Electronic address: sltyzcs@126.com.
Zitieren
APA
Du, W., Peng, X. Y., Li, W., Attiq, U. R., Ge, M. W., Shen, L. T., Feng, R., Zhong, K., Gao, S. Q., & Chen, H. L. (2026). Ethnopharmacology, pharmacokinetics, and antitumor potential of Resina Draconis (Dragon's Blood): A systematic review connecting traditional use to molecular mechanisms. Journal of Ethnopharmacology, 367, 121702. https://doi.org/10.1016/j.jep.2026.121702
Vancouver
Du W, Peng XY, Li W, Attiq UR, Ge MW, Shen LT, et al. Ethnopharmacology, pharmacokinetics, and antitumor potential of Resina Draconis (Dragon's Blood): A systematic review connecting traditional use to molecular mechanisms. Journal of Ethnopharmacology. 2026;367:121702. doi:10.1016/j.jep.2026.121702
BibTeX
@article{Du2026,
author = {Du, Wei and Peng, Xi-Yuan and Li, Wei and Attiq, Ur-Rehman and Ge, Meng-Wei and Shen, Lu-Ting and Feng, Rui and Zhong, Kang and Gao, Si-Qi and Chen, Hong-Lin},
title = {Ethnopharmacology, pharmacokinetics, and antitumor potential of Resina Draconis (Dragon's Blood): A systematic review connecting traditional use to molecular mechanisms},
journal = {Journal of Ethnopharmacology},
year = {2026},
volume = {367},
pages = {121702},
doi = {10.1016/j.jep.2026.121702}
}
EUVIMED